| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V56763 | F7H inhibitor | 897109-93-2 | F7H is a Frizzled receptor FZD7 antagonist (IC50= 1.25 μM). |
|
V56654 | FAPI-4 | 2374782-02-0 | FAPI-4 is a quinoline-based theranostic ligand targeting fibroblast activating protein. |
|
V56601 | Feruloyltyramine | 65646-26-6 | Ferulamide is extracted from cannabis seeds, roots, leaves, and resin; causes hypothermia and uncoordinated movements in mice; moupinamide is the (E)-isomer. |
|
V56658 | Fmoc-Cit-PABA | 870487-04-0 | Fmoc-Cit-PABA is a bioactive peptide linker that can be used for drug conjugate synthesis or ADC synthesis. |
|
V56643 | FR054 | 35954-65-5 | FR054 is an inhibitor (blocker/antagonist) of the hexosamine biosynthetic pathway (HBP) enzyme PGM3 and has significant anti-breast cancer effects. |
|
V56596 | Gcase activator 2 | 2759897-35-1 | Gcase activator 2 (compound 14) is a pyrrole[2,3-b]pyrazine and a β-glucocerebrosidase (Gcase) activator (EC50=3.8 μM). |
|
V56584 | GFP16 | 749212-56-4 | GFP16 is a low-affinity antiprion compound. |
|
V56661 | GPAT-IN-1 | 1204347-51-2 | GPAT-IN-1 is a glycerol 3-phosphate acyltransferase (GPAT) inhibitor (antagonist) with IC50 of 8.9 μM. |
|
V56687 | GSK251 | 2125968-05-8 | GSK251 is a highly efficient, selective, orally bioavailable PI3Kδ inhibitor (antagonist) with a novel binding mode. |
|
V56589 | GSK3β Inhibitor II | 478482-75-6 | GSK3β inhibitor II is an inhibitor (blocker/antagonist) of GSK3β. |
|
V56712 | GW438014 free base | 469861-48-1 | GW438014A is a selective NPY-Y5 receptor antagonist. |
|
V56812 | GW590735 | 622402-22-6 | GW590735 is a potent and specific PPARα agonist/activator with EC50 of 4 nM for expressing a GAL4-responsive reporter gene and is at least 500-fold more selective than PPARγ and PPARδ. |
|
V56583 | GW6340 | 405910-78-3 | GW6340 is a gut-specific LXR agonist. |
|
V56653 | h-NTPDase8-IN-1 | 716358-51-9 | h-NTPDase8-IN-1 (compound 2d) is a sulfamoylbenzamide-based selective inhibitor of h-NTPDases8 (IC50=0.28 μM). |
|
V56746 | HaloPROTAC3 | 1799506-07-2 | HaloPROTAC3 is a degrader of HaloTag fusion proteins. |
|
V56580 | hCAII-IN-8 | 952306-80-8 | hCAII-IN-8 is an amide and a selective carbonic anhydrase (CA) inhibitor (antagonist) with IC50 of 0.18 μM for hCA II. |
|
V56808 | hCAII-IN-9 | 2878477-18-8 | hCAII-IN-9 is a potent carbonic anhydrase inhibitor (antagonist) with IC50s of 1.18 μM (hCA II), 0.17 μM (hCA IX), and 2.99 μM (hCA XII). |
|
V56585 | HG106 | 928712-10-1 | HG106 is a potent SLC7A11 inhibitor. |
|
V56695 | HHS-0701 | 2851993-91-2 | HHS-0701 is a sulfur triazole exchange (SuTEx) ligand and a potent inhibitor of tyrosine-responsive prostaglandin reductase 2 (PTGR2). |
|
V51975 | HP661 | 2938220-60-9 | HP661 is an orally bioactive oxidative phosphorylation (OXPHOS) inhibitor that can effectively block the activity of mitochondrial complex I and reduce the production of reactive oxygen species. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
